Concepedia

Publication | Open Access

Azithromycin for the Secondary Prevention of Coronary Events

374

Citations

19

References

2005

Year

Abstract

A one-year course of weekly azithromycin did not alter the risk of cardiac events among patients with stable coronary artery disease.

References

YearCitations

Page 1